This site is intended for health professionals only

Pressure put on Government to make GPs screen for atrial fibrillation

Cardiovascular experts, along with UK MPs, are mounting a new push to overturn the UK National Screening Committee’s decision to rule out a GP screening programme for atrial fibrillation (AF).

Last year Pulse revealed that GP practices could be offered incentives through QOF to screen elderly people for atrial fibrillation, under new NICE plans, but the initiative found opposition from GP leaders.

The move comes as international collaboration AF-Screen, comprising over 130 cardiologists, neurologists, GPs, health economists, nurses, pharmacists and patient support organisations from 33 countries, is leading, a global drive to introduce national screening programs for atrial fibrillation.

A white paper, just published in the Journal of the American Heart Association, Circulation, calls for governments worldwide to introduce screening for atrial fibrillation in all people aged 65 years and over in a bid to cut the risk of stroke and death.

In the UK, the Arrhythmia Alliance, together with partner organisation AF Association, and the All Party Parliamentary Group on atrial fibrillation, are lobbying the UK National Screening Committee to reconsider its decision from 2014.

The Committee dismissed the notion of a systemic GP screening programme as it remained unconvinced that it was beneficial.

Trudie Lobban, chief executive and founder Arrhythmia Alliance, and a member of the AF-Screen collaboration, said: ‘In the UK, we know that there are over half a million people with undiagnosed AF, who are at risk of suffering a debilitating, life-threatening AF-related stroke.’

She added: ‘We welcome the publication of this important white paper which confirms the unquestionable value of a national screening programme for AF in people aged 65 and over.’

Professor Richard Schilling, medical director of the Atrial Fibrillation Association, said: ‘Widespread screening for asymptomatic atrial fibrillation in people aged 65 years and above could cost-effectively reduce strokes and their associated disability, and help save lives.

‘However, this is not yet widely recommended in guidelines.’

But GP leaders have argued that screening for atrial fibrillation went against National Screening Committee advice.

Dr Peter Swinyard, chair of the Family Doctor Association, questioned the efficacy of a full-scale screening programme, describing it as another ‘box-ticking’ exercise.

The National Screening Committee review in 2014 found that it was ‘not clear that those identified as at risk through screening would benefit from early diagnosis’.

The evidence review also highlighted concerns over the available test and the quality of current treatment pathways for atrial fibrillation. The next review is expected in 2017/18.

The white paper, Screening for Atrial Fibrillation, A Report of the AF-SCREEN International Collaboration, has 60 contributing authors and was published in Circulation (9 May 2017 issue 19; Vol 135).


Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.